By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Complete Genomics rose 36 percent in early trading today on news that it was selected by the Mayo Clinic's Center for Individualized Medicine to provide outsourced whole genome sequencing.

Shares of Complete Genomics were trading at $4.48 on the Nasdaq.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.